#United States #INOVIO #DNA medicines #Plymouth Meeting #HPV

INOVIO's Upcoming Conferences in 2026

INOVIO Pharmaceuticals, Inc., a prominent biotechnology company known for its innovative DNA medicines, has outlined its participation in several noteworthy scientific and investor conferences set for 2026. These events serve as platforms for showcasing significant advancements in the development and commercialization of treatments aimed at tackling HPV-associated diseases, cancer, and other infectious diseases.

Conference Schedule:

1. American Association for Cancer Research Immuno-Oncology Conference
- Location: Los Angeles, CA
- Date: February 18, 2026
- Time: 7:30 PM - 10:00 PM PT
- Session Type: Poster Session A
- Presentation Topic: Treatment of recurrent respiratory papillomatosis (RRP) with INO-3107, highlighting its efficacy in inducing pro-inflammatory CD4+ T cell responses.

2. Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Location: Virtual
- Date: February 25, 2026
- Time: 12:40 PM - 1:10 PM ET
- Format: Fireside Chat Webcast
- Webcast Link: Join Here

3. Festival of Biologics
- Location: San Diego, CA
- Date: March 4, 2026
- Time: 3:10 PM PT
- Presentation Topic: A Phase 1 trial on the safety and pharmacokinetics of SARS-CoV-2 DNA-Encoded Monoclonal Antibodies (DMAbs) in healthy adults.

4. Citizens Life Sciences Conference
- Location: Miami Beach, FL
- Date: March 10, 2026
- Time: 1:40 PM - 2:05 PM ET
- Format: Fireside Chat
- Webcast Link: Join Here

Following these presentations, INOVIO will make available abstracts on its official website, offering a deeper look into the research and findings shared at these events. Additionally, investors can revisit the discussions through recorded sessions that will remain accessible for 90 days post-event on the INOVIO events page.

Management Engagement

INOVIO's management team plans to meet one-on-one with investors during these conferences, promoting direct engagement and dialogue around their cutting-edge research and future initiatives. This personal interaction is a testament to INOVIO's commitment to transparency and its proactive approach toward investor relations.

INOVIO's Vision

INOVIO aims to lead the charge in developing the next generation of DNA medicines, addressing major health challenges such as HPV-related diseases and cancer. By leveraging its innovative technology, INOVIO empowers the body to produce its own defenses, marking a significant leap in treatment methodologies. For more detailed information about INOVIO and its projects, visit INOVIO's Website.

Conclusion

The upcoming participation in these conferences underscores INOVIO's dedication to advancing biotechnological research and fostering investor relations, setting the stage for promising breakthroughs in the field of medicine. Stakeholders and interested parties are encouraged to tune into these sessions to gain insights into the future of DNA therapeutics.